Javier Oliver
Impact in
- Oncology top 10%
- PARP inhibition in cancer therapy
- Polyomavirus and related diseases
- Immunology top 10%
Papers in
-
- DNA Repair Mechanisms 5
- Oncology 13
- Cancer Immunotherapy and Biomarkers 6
- Co-authors
- Javier Martı́n (17 shared papers)Miguel Ángel López‐Nevot (13 shared papers)Véronique Rolli (1 shared paper)Carlotta Trucco (2 shared papers)Eric Flatter (2 shared papers)Gilbert de Murcia (1 shared paper)Valérie Schreiber (1 shared paper)Josiane Ménissier‐de Murcia (2 shared papers)
In The Last Decade
Javier Oliver
48 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 105
- Oncology 418
- Immunology 239
- Cancer Research 166
- Genetics 244
- Molecular Biology 586
Countries citing papers authored by Javier Oliver
This map shows the geographic impact of Javier Oliver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javier Oliver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javier Oliver more than expected).
Fields of papers citing papers by Javier Oliver
This network shows the impact of papers produced by Javier Oliver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javier Oliver. The network helps show where Javier Oliver may publish in the future.
Co-authors
The 25 scholars most cited alongside Javier Oliver, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 287 | |
| 2 | 2017 | 79 | |
| 3 | 2009 | 75 | |
| 4 | 2014 | 73 | |
| 5 | 2007 | 68 | |
| 6 | 2007 | 60 | |
| 7 | 1996 | 38 | |
| 8 | 2005 | 36 | |
| 9 | 2015 | 28 | |
| 10 | 2005 | 27 | |
| 11 | 2021 | 26 | |
| 12 | 2012 | 23 | |
| 13 | 2023 | 23 | |
| 14 | 2005 | 22 | |
| 15 | 2006 | 22 | |
| 16 | 2005 | 22 | |
| 17 | Association of a functional inducible nitric oxide synthase promoter variant with susceptibility to biopsy-proven giant cell arteritis. | 2005 | 20 |
| 18 | Lack of association of a functional single nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with susceptibility to biopsy-proven giant cell arteritis. | 2005 | 17 |
| 19 | 2017 | 14 | |
| 20 | 2007 | 13 |
About Javier Oliver
Javier Oliver is a scholar working on Molecular Biology, Oncology, Immunology, Cancer Research and Genetics, having authored 51 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (8 papers), Cancer Immunotherapy and Biomarkers (6 papers), DNA Repair Mechanisms (5 papers), Inflammatory Bowel Disease (5 papers), Immune Cell Function and Interaction (4 papers), Galectins and Cancer Biology (3 papers), BRCA gene mutations in cancer (3 papers) and T-cell and B-cell Immunology (3 papers). The work is most often cited by research in Oncology (418 citations), Immunology (239 citations), Cancer Research (166 citations), Genetics (244 citations) and Molecular Biology (586 citations). Javier Oliver has collaborated with scholars based in Spain, Sweden and France. Frequent co-authors include Javier Martı́n, Miguel Ángel López‐Nevot, Véronique Rolli, Carlotta Trucco, Eric Flatter, Gilbert de Murcia, Valérie Schreiber, Josiane Ménissier‐de Murcia, Françoise Dantzer and Claude Niedergang. Their work appears in journals such as Cancer Research, International Journal of Molecular Sciences, Biomedicines, Human Immunology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.